COMMON STOCK PURCHASE WARRANT ADVAXIS, INC.Advaxis, Inc. • April 12th, 2021 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ___________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after such date, if ever, that is fourteen (14) days after the Company (as defined below) files an amendment to the Company’s Amended and Restated Certificate of Incorporation (as amended to date, the “Charter”) to increase the number of authorized shares of common stock, $0.001 par value per share from 170,000,000 shares to 300,000,000 shares (the “Authorized Shares Amendment”) with the Delaware Secretary of State (the “Initial Exercise Date”) and on or prior to the date that is five years after the Initial Exercise Date (the “Termination Date”), but not thereafter, to subscribe for and purchase from Advaxis, Inc., a Delaware corporation (the “Company”), up to _____ shares of common stock, par value $0.001 per share (the
PRE-FUNDED COMMON STOCK PURCHASE WARRANT ADVAXIS, INC.Advaxis, Inc. • April 12th, 2021 • Pharmaceutical preparations
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Advaxis, Inc., a Delaware corporation (the “Company”), up to ______ shares of common stock, par value $0.001 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to the terms of that certain Securities Purchase Agreement (the “Purchase Agreement”), dated April 12, 2021, among the Company and the Holder.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 12th, 2021 • Advaxis, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of April 12, 2021 between Advaxis, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Advaxis, Inc.Advaxis, Inc. • April 12th, 2021 • Pharmaceutical preparations • New York
FORM OF INVESTOR AGREEMENTForm of Investor Agreement • April 12th, 2021 • Advaxis, Inc. • Pharmaceutical preparations
This agreement (the “Investor Agreement”) is being delivered to you in connection with an understanding by and between Advaxis Inc., a Delaware corporation (the “Company”), and the person or persons named on the signature pages hereto (collectively, the “Holder”).
